ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.605,73
0,36%
S&P 500
5.319,36
0,30%
US Dollar vs BRL
5,0951
-0,16%
Bitcoin
67.449,90
1,95%
Brent Oil
83,405
-0,23%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Liquidia Corporation (LQDA)

  7. Liquidia Corporation (LQDA) Notícias

LQDA

Liquidia (LQDA)

Liquidia Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:LQDA
DataHoraFonteTítuloCódigoCompanhia
14/05/202417:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
13/05/202418:43GlobeNewswire Inc.Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
13/05/202418:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LQDALiquidia Corporation
10/05/202409:00GlobeNewswire Inc.Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILDNASDAQ:LQDALiquidia Corporation
07/05/202409:30GlobeNewswire Inc.Liquidia Corporation to Present at BofA Securities Health Care Conference 2024NASDAQ:LQDALiquidia Corporation
07/05/202409:00GlobeNewswire Inc.Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024NASDAQ:LQDALiquidia Corporation
02/04/202410:00GlobeNewswire Inc.Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
01/04/202407:00GlobeNewswire Inc.Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powderNASDAQ:LQDALiquidia Corporation
13/03/202407:00GlobeNewswire Inc.Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
06/03/202408:30GlobeNewswire Inc.Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024NASDAQ:LQDALiquidia Corporation
04/03/202421:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
30/01/202408:30GlobeNewswire Inc.Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual CongressNASDAQ:LQDALiquidia Corporation
25/01/202408:00GlobeNewswire Inc.Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powderNASDAQ:LQDALiquidia Corporation
19/01/202408:30GlobeNewswire Inc.Liquidia Corporation Announces Updates to Operations LeadershipNASDAQ:LQDALiquidia Corporation
16/01/202409:42Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LQDALiquidia Corporation
08/01/202410:22GlobeNewswire Inc.Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files CounterclaimsNASDAQ:LQDALiquidia Corporation
05/01/202408:45GlobeNewswire Inc.Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILDNASDAQ:LQDALiquidia Corporation
04/01/202411:10GlobeNewswire Inc.Liquidia Corporation Announces $100 Million in New FinancingsNASDAQ:LQDALiquidia Corporation
04/01/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LQDALiquidia Corporation
02/01/202408:45GlobeNewswire Inc.Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
28/12/202318:30Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:LQDALiquidia Corporation
22/12/202318:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LQDALiquidia Corporation
20/12/202318:56GlobeNewswire Inc.U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 (‘793 Patent)NASDAQ:LQDALiquidia Corporation
12/12/202318:41Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NASDAQ:LQDALiquidia Corporation
12/12/202309:13GlobeNewswire Inc.Liquidia Announces Pricing of Public Offering of Common StockNASDAQ:LQDALiquidia Corporation
07/11/202308:30GlobeNewswire Inc.Liquidia Corporation Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
31/10/202307:30GlobeNewswire Inc.Liquidia Corporation to Report Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:LQDALiquidia Corporation
02/10/202308:00GlobeNewswire Inc.Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of DirectorsNASDAQ:LQDALiquidia Corporation
25/09/202317:09GlobeNewswire Inc.FDA Accepts Submission to Add PH-ILD to YUTREPIA™ LabelNASDAQ:LQDALiquidia Corporation
06/09/202317:30GlobeNewswire Inc.United Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Already Found to Be Invalid by U.S. Patent OfficeNASDAQ:LQDALiquidia Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:LQDA

Seu Histórico Recente

LSE
40LD
Municpltynts36
NASDAQ
XLTC
Excel
BOV
P1SX34R
Phillips 66
EU
CADCD
Cades CADES4%15DEC2025
BIT
P1S2K6
NLBNPIT1S2K6 20240621 400
USOTC
VCHYF
V Technology (PK)
NASDAQ
ENCPU
Energem
USOTC
NCLTF
Nitori (PK)
NASDAQI
KRX
KBW Nasdaq Regional Bank...
TSXV
IXI
Indigo Explorations
LSE
SY73
Erm Fund.90 A1
BOV
PAGS34Q
PagSeguro Digital
LSE
EPB6
Petrob Glob Fin
AMEX
MGNR
American Beacon Glg Natu...
EU
DBRBH
Departement Bouches du R...
BIT
P1Z7I0
NLBNPIT1Z7I0 20991231 12...
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados